Peer-Reviewed Publications

      Aerosols sampling using a new cryogenic instrument

      Plata, N.; Hofer, I.; Roudier, S.; Schaller, J.-P.
      Published
      Sep 20, 2006
      DOI
      10.1016/j.jaerosci.2006.07.003
      Link to publication
      Topic
      Summary

      A new cryogenic instrument was designed for the trapping of aerosols such as cigarette mainstream smoke at low temperature. The technique enabled the trapping of the mainstream smoke of a single cigarette and the particulate and vapor phases were trapped simultaneously. 2R4F reference cigarettes were smoked under International Standard Organization (ISO) regime and trapped at low temperature using the cryogenic instrument. After trapping, the mainstream smoke of the 2R4F reference cigarette was diluted with a solvent and selected smoke components could be quantified using gas-mass spectrometry (GCMS) and high-performance liquid chromatography (HPLC). The capability of the instrument for trapping the mainstream smoke was demonstrated. The feasibility of the procedure for the detection and the quantification of a large range of smoke components including carbonyls, alkaloids and organic volatile compounds (VOC) in the mainstream of a single cigarette was also shown.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.